Wealth Enhancement Advisory Services, LLC Gain Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 15,556 shares of GANX stock, worth $30,489. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,556Holding current value
$30,489% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GANX
# of Institutions
40Shares Held
4.49MCall Options Held
37.9KPut Options Held
0-
Jones Financial Companies Lllp677KShares$1.33 Million0.0% of portfolio
-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$1.15 Million0.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$1.11 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA534KShares$1.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA290KShares$569,3050.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $23.3M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...